Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-05-03
2005-05-03
Foley, Shannon (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S199100, C424S204100, C435S236000, C536S023500, C536S023720
Reexamination Certificate
active
06887479
ABSTRACT:
The present invention describes recombinant RV mutants comprising a combine mutation in two different parts of the viral genome, involving the P and the G genes. The mutations in the P gene preferably encompass residues 139 to 170, more preferably residue 139 to 149, most preferably residues 143-149. The mutation can be a substitution or deletion of one or more amino acids in the above region, as well as combinations of deletion and substitution.
REFERENCES:
patent: 0032755 (2000-06-01), None
patent: WO 0032755 (2000-06-01), None
Dietzschold et al. Rhabdoviruses. In B.N. Fields et al. (ed.), Fields Virology, 3rd ed. Philadelphia: Lippencott-Raven Publishers 1996: 1144.*
Wild et al. Journal of General Virology. 1981; 57: 169-177.*
Jacob et al. Journal of Virology. Nov., 2000; 74(21): 10217-10222.*
Mebatsion et al. (PNAS. 1996; 93: 7310-7314.*
Schnell M J et al: Infectious Rabies Viruses From Cloned CDNA: EMBO Journal, Oxford University Press, Surrey, GB, vol. 13, No. 18, Sep. 1, 1994 pp. 4195-4203.
Raux Helene et al: “Interaction of the rabies virus P protein with the LC8 dynein light chain.”, Journal of Virology, vol. 74, No. 21, Nov. 2000, pp. 10212-10216.
Jacob Yves et al: “Cytoplasmic dynein LC8 1-7, 9-14 interacts with lyssavirus phosphoprotein.”, Journal of Virology, vol. 74, No. 21, Nov. 2000, pp. 10217-10222.
Mebatsion et al: “Highly stable expression of a foreing gene from rabies virus vectors”, Proceedings of the National Academy of Sciences of USA, Washington, US, vol. 93, Jul. 1996, pp. 7310-7314.
Jacob Yves et al: “Functional interaction map of lyssavirus phosphoprotein: Identification of the minimal transcription domains.”, Journal of Virology, vol. 75, No. 20, Oct. 2001, pp. 9613-9622.
Mebatsion Teshome: “Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein.”, Journal of Virology, vol. 75, No. 23, Dec. 2001, pp. 11496-11502.
Akzo Nobel N.V.
Foley Shannon
Ramey III William P.
LandOfFree
Attenuated recombinant rabies virus mutants and live... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Attenuated recombinant rabies virus mutants and live..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Attenuated recombinant rabies virus mutants and live... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3459140